A

An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner’s lesions

World Journal of Urology, vol. 39, pp. 2065–2071

Authors 11

  1. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  2. Astellas Pharma (Japan) · Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands. olivier.vantill@astellas.com

    Astellas Pharma Inc, Medical & Development, Medical Specialties Therapeutic Area. 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan. olivier.vantill@astellas.com

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  3. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  4. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  5. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  6. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  7. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  8. Astellas Pharma (Netherlands)

    Affiliation as printed

    Astellas Pharma Europe B.V, Leiden, The Netherlands

  9. Queen's University

    Affiliation as printed

    Department of Urology, Queens University, Kingston, Canada

  10. Stanford University

    Affiliation as printed

    Department of Urology, Stanford University, Stanford, CA, USA

  11. University of Copenhagen

    Affiliation as printed

    Department of Urology, University of Copenhagen, Copenhagen, Denmark

Cited by 15 stored of 15

15 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 30